• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

MEI Pharma Inc

+ Add to Watchlist

MEIP:US

8.0500 USD 0.0600 0.75%

As of 17:20:00 ET on 10/31/2014.

Snapshot for MEI Pharma Inc (MEIP)

Open: 8.1000 Day's Range: 7.8500 - 8.1000 Volume: 68,836
Previous Close: 7.9900 52wk Range: 5.5100 - 13.9800 1-Yr Rtn: +0.37%

Stock Chart for MEIP

No chart data available.
  • MEIP:US 8.0500
  • 1D
  • 1M
  • 1Y
7.9900
Interactive MEIP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MEIP

Current P/E Ratio (ttm) -
Estimated P/E(06/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.3500
Est. EPS (USD) (06/2015) -1.3570
Est. PEG Ratio -
Market Cap (M USD) 173.94
Shares Outstanding (M) 21.61
30 Day Average Volume 73,606
Price/Book (mrq) 3.8489
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MEIP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for MEIP

MEI Pharma, Inc. is an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism. The Company's lead drug candidates have been shown in laboratory studies to interact with specific enzyme targets resulting in inhibition of tumor cell metabolism, a function critical for cancer cell survival.

Daniel P GoldPresident/CEOThomas M ZechCFO/Secretary
Robert D MassChief Medical OfficerDavid M UrsoSenior VP:Corporate Dev
More Company Profile & Key Executives for MEIP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil